2006
DOI: 10.1016/j.ejca.2005.10.033
|View full text |Cite
|
Sign up to set email alerts
|

Why don’t cancer patients enter clinical trials? A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
25
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(25 citation statements)
references
References 36 publications
0
25
0
Order By: Relevance
“…Patient-related barriers include cognitive barriers, such as lack of awareness or understanding about CTs [13], structural barriers, which include concerns about participation costs, travel and insurance coverage [14], and psychological barriers, including misperceptions, distrust, and fear [15]. Physician-related barriers include limited knowledge of ongoing CTs, unsupportive attitudes, and a lack of motivation to enroll patients [16,17].…”
mentioning
confidence: 98%
“…Patient-related barriers include cognitive barriers, such as lack of awareness or understanding about CTs [13], structural barriers, which include concerns about participation costs, travel and insurance coverage [14], and psychological barriers, including misperceptions, distrust, and fear [15]. Physician-related barriers include limited knowledge of ongoing CTs, unsupportive attitudes, and a lack of motivation to enroll patients [16,17].…”
mentioning
confidence: 98%
“…Although efforts are being made to increase the number of adult cancer patients entered into clinical trials, only around 10% of eligible patients are accrued [74]. Barriers to recruitment include attitudes of some doctors toward clinical trials [20] and patient concerns with the research process and its implications [71]. Superior survival in children has also been attributed to the fact that they are more resilient than adults and can tolerate more aggressive therapy.…”
Section: Survival Ratesmentioning
confidence: 99%
“…Operating under the assumption that the mass media convey most risk information to the public, it incorporates ideas that describe how the audiences select media channels to gratify their varying needs [41]. In the context of clinical trial communication, however, most people still rely on their doctors as primary source of information [4,8,42]. Therefore, this component of the RISP model warrants some conceptual adaptation.…”
Section: Key Components Of the Risp Modelmentioning
confidence: 99%